^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Chordoma
    Drug:imatinib (YD312) (c-KIT inhibitor, SCF signal transduction pathway inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    Chordoma: Useful in Certain Circumstances...Imatinib + Cisplatin
    Secondary therapy:
    cisplatin
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    Chordoma: Other Recommended Regimens...Imatinib
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    Chordoma: Useful in Certain Circumstances...Imatinib + Sirolimus
    Secondary therapy:
    sirolimus